Damage award sharply cut in Takeda, Lilly case over diabetes drug

Takeda Pharmaceutical Co. and Eli Lilly & Co. had a $9-billion punitive damage award over claims that the drug makers hid the cancer risks of their Actos diabetes medicine sharply reduced.

No New Trial In Actos MDL Bellwether Case, But Punitives Are Cut From $9 Billion To $36 Million

LAFAYETTE, La. — (Mealey’s) Takeda Pharmaceutical Co. Ltd. and Eli Lilly and Co. will not get a new trial in the first Actos bladder cancer multidistrict litigation bellwether case, but a Louisiana federal judge on Oct. 27 reduced the $9 billion...